Answers are grounded in this paper and cite their sources.
The co-occurrence of restrictive-eating disorders, most commonly anorexia nervosa (AN) and gender-related distress (GRD) is increasingly noted in clinical settings. Clinicians often face unique challenges in treating this potentially high-risk population, who may show low motivation for eating disorder treatment (EDT) while demonstrating a strong investment in accessing gender-affirming medical treatment (GAMT), often requiring lifelong interventions. This tension, combined with the lack of relevant clinical guidance and scientific evidence, can contribute to therapeutic ruptures and premature discontinuation of care. In this paper, I reflect on clinical and psychotherapeutic interventions for adolescents presenting with both AN and GRD, proposing a framework to support clinical formulation and collaborative practice across specialist services. Through a case vignette, I explore the challenges and opportunities involved in building a safe therapeutic alliance with a birth-registered female adolescent experiencing both difficulties. I highlight the importance of adapting and integrating evidence-informed treatment pathways to address these complex, co-occurring conditions. Key areas of focus include physical and mental health safety, cognitive flexibility, and the need for a collaborative-exploratory treatment process. It is essential that England’s National Health Service (NHS) and European public health systems develop relevant guidelines that are evidence-based, developmentally informed, and family-focused.
No takes yet. Share an insight, caveat, or question.
Anastassis Spiliadis (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: